Please assess the completion status of the following clinical trial:

Trial Title: Gatorade/Miralax With or Without Bisacodyl Versus NuLytely for Colonoscopy Preparation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~1. Patients at least 18 years old planning to undergo an elective colonoscopy.~Exclusion Criteria:~1. Patients who are allergic or intolerant to any on the study drugs.~2. Pregnant patients.~3. Patients who required multiple day colon preparation in the past.~4. Patients with ileus, gastrointestinal obstruction, gastric retention, bowel perforation, toxic colitis or toxic megacolon would not be considered elective colonoscopies and are excluded.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Nulytely (Type: ACTIVE_COMPARATOR): Nulytely (or Trilyte) 128 oz (1 gallon) to be consumed from about 5 PM to 9 PM the night before the colonoscopy.
- Gatorade/Miralax + Placebo (Type: EXPERIMENTAL): Gatorade 64 oz (1/2 gallon), Miralax 306 g and a placebo (two 0.4 mg folic acid pills) to be consumed the day before the colonoscopy as follows: Miralax 51 g and placebo at 12 noon. Gatorade 64 oz mixed with Miralax 255 g from about 5 PM to 9 PM.
- Gatorade/Miralax + Bisacodyl (Type: EXPERIMENTAL): Gatorade 64 oz (1/2 gallon), Miralax 306 g and Bisacodyl 10 mg (two 5 mg pills) to be consumed the day before the colonoscopy as follows: Miralax 51 g and Bisacodyl 10 mg at 12 noon. Gatorade 64 oz mixed with Miralax 255 g from about 5 PM to 9 PM.

Based on this trial design, predict the completion outcome and termination type (if applicable).